Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA).

Talbot TR, Babcock H, Cotton D, Maragakis LL, Poland GA, Septimus EJ, Tapper ML, Weber DJ.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):981-3. doi: 10.1086/667772.

PMID:
22961016
2.

Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.

Mallory RM, Yi T, Ambrose CS.

Vaccine. 2011 Jun 10;29(26):4322-7. doi: 10.1016/j.vaccine.2011.04.022. Epub 2011 Apr 20.

PMID:
21513761
3.

Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.

Coelingh K, Olajide IR, MacDonald P, Yogev R.

Expert Rev Vaccines. 2015;14(10):1331-46. doi: 10.1586/14760584.2015.1078732. Epub 2015 Sep 7. Review.

PMID:
26372891
4.

Live attenuated influenza vaccine tetravalent: a clinical review.

Bandell AR, Simões EA.

Expert Rev Vaccines. 2015 Jul;14(7):963-73. doi: 10.1586/14760584.2015.1034695. Epub 2015 Apr 11. Review.

PMID:
25864428
5.

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.

Vaccine. 2008 Sep 8;26(38):4940-6. doi: 10.1016/j.vaccine.2008.07.013. Epub 2008 Jul 26.

PMID:
18662737
6.

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.

J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23.

PMID:
21949042
7.

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.

Isakova-Sivak I, Rudenko L.

Expert Rev Vaccines. 2015;14(10):1313-29. doi: 10.1586/14760584.2015.1075883. Epub 2015 Aug 6. Review.

PMID:
26289975
8.

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.

PMID:
11740317
9.

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference.

Bandell A, Woo J, Coelingh K.

Expert Rev Vaccines. 2011 Aug;10(8):1131-41. doi: 10.1586/erv.11.73. Review.

PMID:
21854309
10.

Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada.

Dubé E, Gagnon D, Kiely M, Boulianne N, Landry M.

Hum Vaccin Immunother. 2015;11(4):956-60. doi: 10.1080/21645515.2015.1009816.

11.

Editorial commentary: Changing epidemiology of influenza B virus.

Glezen WP.

Clin Infect Dis. 2014 Dec 1;59(11):1525-6. doi: 10.1093/cid/ciu668. Epub 2014 Aug 19. No abstract available.

PMID:
25139967
12.

Influenza vaccine 2007-2008.

[No authors listed]

Med Lett Drugs Ther. 2007 Oct 8;49(1271):81-3. No abstract available.

PMID:
17912142
13.

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB.

J Infect Dis. 2000 Feb;181(2):725-8.

PMID:
10669363
14.

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.

Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.

Expert Rev Vaccines. 2004 Dec;3(6):643-54. Review.

PMID:
15606348
15.

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.

Toback SL, Levin MJ, Block SL, Belshe RB, Ambrose CS, Falloon J.

Expert Rev Vaccines. 2012 Nov;11(11):1293-303. doi: 10.1586/erv.12.108. Epub 2012 Nov 14. Review.

PMID:
23151111
16.

Live attenuated influenza virus vaccines: new options for the prevention of influenza.

Nichol KL.

Vaccine. 2001 Aug 14;19(31):4373-7. Review.

PMID:
11483261
17.

Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.

Miyazaki C, Nakayama M, Tanaka Y, Kusuhara K, Okada K, Tokugawa K, Ueda K, Shibata R, Nishima S, Yamane N, et al.

Vaccine. 1993;11(8):853-8.

18.

Influenza vaccines.

Brede HD.

Int Arch Allergy Immunol. 1995 Dec;108(4):318-20. Review.

PMID:
7580301
19.

Localized mucosal response to intranasal live attenuated influenza vaccine in adults.

Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.

J Infect Dis. 2013 Jan 1;207(1):115-24. doi: 10.1093/infdis/jis641. Epub 2012 Oct 19.

20.

[Preventing influenza: recommendations for the 2005-2006 season].

Le Riverend E.

Rev Panam Salud Publica. 2005 Sep;18(3):210-5. Spanish. No abstract available.

PMID:
16269123

Supplemental Content

Support Center